Business AstraZeneca to acquire EsoBiotec for up to $1 billionBy Gazet InternationalMarch 17, 20250 AstraZeneca will acquire biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec’s “Engineered NanoBody Lentiviral (ENaBL) platform can genetically modify immune cells directly inside the body,… Read More
